NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Francisco Javier
Narváez García
Publicaciones en las que colabora con Francisco Javier Narváez García (22)
2022
-
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
2021
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
2020
-
Biologic therapy in refractory non-multiple sclerosis optic neuritis isolated or associated to immune-mediated inflammatory diseases. A multicenter study
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-13
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA
PLoS ONE, Vol. 9, Núm. 11
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745
-
Tocilizumab in refractory aortitis: A study on 16 patients and literature review
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
2013
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
2011
-
A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601
-
Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 29, Núm. 1 SUPPL. 64